cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Werewolf Therapeutics Inc
2 own
4 watching
Current Price
$3.47
$0.11
(3.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
122.49M
52-Week High
52-Week High
7.51
52-Week Low
52-Week Low
1.39
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization122.49M
icon52-Week High7.51
icon52-Week Low1.39
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Werewolf Therapeutics Inc do?
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body s immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Werewolf Therapeutics Inc make?
News & Events about Werewolf Therapeutics Inc.
Globe Newswire
1month ago
WATERTOWN, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the Company or Werewolf) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics, announced the publication in Cancer Immunology Research Online First ...
Globe Newswire
2 months ago
WATERTOWN, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the Company or Werewolf) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the bodys immune system for the treatment of ...
Globe Newswire
3 months ago
WTX-330 is designed as systemically delivered, conditionally activated IL-12 therapy Phase 1 Study of WTX-330 is intended to evaluate the safety, tolerability, and clinical activity of WTX-330 in Patients with Advanced or Metastatic Solid Tumors orNon-Hodgkin Lymphoma Second clinical stage program ...
Ticker Report
4 months ago
Werewolf Therapeutics, Inc. (NASDAQ:HOWL Get Rating) Director Ra Capital Management, L.P. purchased 1,853,000 shares of the firms stock in a transaction on Friday, January 6th. The shares were purchased at an average cost of $2.21 per share, with a total value of $4,095,130.00. ...
PR Newswire
4 months ago
Thinking about buying stock in Biora Therapeutics, AMC Entertainment, Werewolf Therapeutics, Broadwind, or BioNano Genomics? Thinking about buying stock in Biora Therapeutics, AMC Entertainment, Werewolf Therapeutics, Broadwind, or BioNano Genomics? PR Newswire NEW YORK, Jan. 11, 2023 NEW YORK...
Frequently Asked Questions
Frequently Asked Questions
What is Werewolf Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Werewolf Therapeutics Inc shares?
plus_minus_icon
How can I buy Werewolf Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Werewolf Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Werewolf Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Werewolf Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Werewolf Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Werewolf Therapeutics Inc?
plus_minus_icon
What percentage is Werewolf Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Werewolf Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.47
$0.11
(3.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00